14,442 Shares in Surgery Partners, Inc. $SGRY Purchased by Camelot Portfolios LLC

Camelot Portfolios LLC acquired a new stake in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 14,442 shares of the company's stock, valued at approximately $321,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of SGRY. AlphaQuest LLC increased its position in Surgery Partners by 112.0% during the 1st quarter. AlphaQuest LLC now owns 1,058 shares of the company's stock valued at $25,000 after purchasing an additional 559 shares during the period. PNC Financial Services Group Inc. boosted its stake in shares of Surgery Partners by 86.4% in the first quarter. PNC Financial Services Group Inc. now owns 1,169 shares of the company's stock worth $28,000 after buying an additional 542 shares during the last quarter. Summit Securities Group LLC purchased a new stake in shares of Surgery Partners during the 1st quarter worth about $31,000. DekaBank Deutsche Girozentrale acquired a new position in shares of Surgery Partners during the 1st quarter worth approximately $65,000. Finally, GAMMA Investing LLC raised its position in shares of Surgery Partners by 7,902.7% in the first quarter. GAMMA Investing LLC now owns 8,883 shares of the company's stock valued at $211,000 after buying an additional 8,772 shares during the last quarter.

Surgery Partners Trading Up 1.2%

SGRY stock opened at $21.85 on Friday. The company has a quick ratio of 1.78, a current ratio of 1.93 and a debt-to-equity ratio of 1.10. Surgery Partners, Inc. has a 52 week low of $18.87 and a 52 week high of $33.37. The company has a market cap of $2.80 billion, a price-to-earnings ratio of -15.28 and a beta of 1.76. The business has a fifty day simple moving average of $22.34 and a 200-day simple moving average of $22.41.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $0.17 EPS for the quarter, topping the consensus estimate of $0.16 by $0.01. The company had revenue of $826.20 million during the quarter, compared to analyst estimates of $816.96 million. Surgery Partners had a positive return on equity of 2.51% and a negative net margin of 5.57%.The business's revenue was up 8.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.21 EPS. On average, equities research analysts expect that Surgery Partners, Inc. will post 0.67 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the stock. Bank of America assumed coverage on shares of Surgery Partners in a research report on Monday, July 28th. They set a "buy" rating and a $28.00 price objective for the company. JPMorgan Chase & Co. initiated coverage on shares of Surgery Partners in a research note on Thursday, September 18th. They issued a "neutral" rating and a $27.00 price target on the stock. Six analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $32.88.

Insider Transactions at Surgery Partners

In other Surgery Partners news, insider Harrison R. Bane sold 9,339 shares of Surgery Partners stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $22.48, for a total value of $209,940.72. Following the transaction, the insider directly owned 117,181 shares of the company's stock, valued at $2,634,228.88. The trade was a 7.38% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Teresa Deluca sold 20,018 shares of the business's stock in a transaction that occurred on Monday, August 11th. The shares were sold at an average price of $22.74, for a total value of $455,209.32. Following the sale, the director owned 45,173 shares in the company, valued at approximately $1,027,234.02. This represents a 30.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.70% of the company's stock.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.

Want to see what other hedge funds are holding SGRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Surgery Partners, Inc. (NASDAQ:SGRY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.